Personal profile
Research interests
T2DM, diabetic kidney disease, gut microbiota, sodium homeostasis
Specialisation
T2DM, diabetic kidney disease, gut microbiota, sodium homeostasis
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Lot Mosterd is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial
Beernink, J. M., Jongs, N., Mosterd, C. M., Scholtes, R. A., Caldwell-McGee, A., Casillas, D., Driscoll, L., Greasley, P. J., Karlsson, C., Hammarstedt, A., Sridhar, V. S., Muskiet, M. H. A., Laverman, G. D., Cherney, D. Z. I., Bjornstad, P., van Raalte, D. H. & Heerspink, H. J. L., Aug 2025, In: Diabetes, Obesity and Metabolism. 27, 8, p. 4415-4426 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Downloads (Pure) -
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure
Lytvyn, Y., Scholtes, R. A., Boorsma, E. M., Sridhar, V. S., Kugathasan, L., Liu, H., Lovblom, L. E., Handoko, L., Mosterd, C. M., Floras, J. S., Burns, K., Osuntokun, T., Voors, A., van Raalte, D. H., Heerspink, H. J. L. & Cherney, D. Z. I., 1 Apr 2025, In: Physiological reports. 13, 7, e70275.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile38 Downloads (Pure) -
Plasma and Urine Metabolites Associated With Nondiabetic Chronic Kidney Disease: The HELIUS Study
Mosterd, C. M., Verhaar, B. J. H., van den Born, B.-J. H., Nieuwdorp, M. & van Raalte, D. H., 1 Jul 2025, In: Kidney medicine. 7, 7, 101009.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile26 Downloads (Pure) -
Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
van der Hoek, S., Koomen, J. V., van Bommel, E. J. M., Mosterd, C. M., Scholtes, R. A., Hesp, A. C., Stevens, J., van Raalte, D. H. & Heerspink, H. J. L., 1 May 2023, In: Journal of Personalized Medicine. 13, 5, 747.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Downloads (Pure) -
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
Scholtes, R. A., Mosterd, C. M., Hesp, A. C., Smits, M. M., Heerspink, H. J. L. & van Raalte, D. H., Jan 2023, In: Diabetes, obesity & metabolism. 25, 1, p. 198-207 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile18 Downloads (Pure)